Companies / EVH Evolent Health, Inc. (EVH)
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Ticker EVH Exchange NYSE Sector Healthcare Industry Health Information Services Market cap $517.87M 52-week range $2.10 - $6.34 Valuation Share price $4.58 (close of Nov 6, 2026) P/E (TTM) -1.01x Price to book 1.39x Price to free cash flow 7.98x Enterprise value $1.34B Book value per share $3.30 Price performance Period Change 1 day +0.88% 5 days +6.51% 1 month +19.27% 3 months +27.58% 6 months +19.58% Year to date +14.50% 1 year -23.67% 3 years -83.73% 5 years -84.57% 10 years -75.11% All time -75.72%
Short interest As of Oct 15, 2026 Short % of float 10.65% Shares short 11.90M Days to cover 5.62 Change since prior report -7.79% Source FINRA consolidated short interest Profitability and growth Return on equity -128.74% Return on invested capital -29.18% Return on assets -28.14% Return on capital employed -27.09% Gross margin 21.31% Net margin -28.49% EBITDA margin -15.69% Revenue growth -26.56% Free cash flow growth 107.00% Cash flow and balance sheet Free cash flow yield (TTM) 12.53% Current ratio 1.26x Net debt to EBITDA -2.53x Latest reported year Period end Dec 31, 2025 Fiscal year 2025 Revenue $1.88B Cost of revenue $1.48B Gross profit $399.88M EBITDA -$294.29M Net income -$534.51M Interest expense $57.47M Income statement by year Period end Revenue Gross profit Net income 2025-12-31 $1.88B $399.88M -$534.51M 2024-12-31 $2.55B $367.35M -$61.62M 2023-12-31 $1.96B $460.47M -$113.04M 2022-12-31 $1.35B $316.58M -$19.16M 2021-12-31 $907.96M $250.41M -$37.60M 2020-12-31 $924.64M - -$334.25M 2019-12-31 $846.38M - -$301.97M 2018-12-31 $627.06M - -$52.66M 2017-12-31 $434.95M - -$60.66M 2016-12-31 $254.19M - -$159.74M
Margins and returns by year Period end Gross margin Net margin Return on equity Return on capital 2025-12-31 21.31% -28.49% -128.74% -29.18% 2024-12-31 14.38% -2.41% -6.15% -2.28% 2023-12-31 23.45% -5.76% -10.59% -2.08% 2022-12-31 23.42% -1.42% -2.23% 0.27% 2021-12-31 27.58% -4.14% -5.42% -4.35% 2020-12-31 - -36.15% -53.95% -26.60% 2019-12-31 - -35.68% -32.50% -22.04% 2018-12-31 - -8.40% -4.43% -3.37% 2017-12-31 - -13.95% -5.80% -5.67% 2016-12-31 - -62.84% -17.51% -21.96%
Cash and debt by year Period end Cash Debt 2025-12-31 $151.86M $970.54M 2024-12-31 $104.20M $490.52M 2023-12-31 $192.82M $597.05M 2022-12-31 $188.20M $412.99M 2021-12-31 $266.28M $215.68M 2020-12-31 $319.00M $263.34M 2019-12-31 $101.01M $293.67M 2018-12-31 $228.32M $221.04M 2017-12-31 $238.43M $121.39M 2016-12-31 $178.90M $120.28M
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 $38.84M $39.74M 2024-12-31 $18.77M $39.75M 2023-12-31 $142.58M $40.50M 2022-12-31 -$11.55M $33.98M 2021-12-31 $38.75M $16.71M 2020-12-31 -$16.23M $14.61M 2019-12-31 -$78.18M $15.62M 2018-12-31 -$60.20M $17.61M 2017-12-31 -$55.81M $20.44M 2016-12-31 -$51.04M $18.60M
Investor relations Past earnings dates Reported Fiscal period EPS estimate 2026-11-05 Sep 2026 -$0.05 2026-08-06 Jun 2026 -$0.10 2026-05-07 Mar 2026 -$0.15 2026-02-24 Dec 2025 -$0.03 2025-11-06 Sep 2025 - 2025-08-07 Jun 2025 - 2025-05-08 Mar 2025 -$0.01 2025-02-20 Dec 2024 -$0.11
Filings and sources Company website evolent.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports Similar companies Veeva Systems Inc (VEEV) · HealthEquity, Inc. (HQY) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV) · IDEXX Laboratories Inc (IDXX)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades